携带相同瘤原体驱动的干细胞的不同位会影响骨髓增殖性瘤的病变发生和治疗反应
Elodie Grockowiak1,2,3, Claudia Korn1,2,3, Justyna Rak1,2,3
1National Health Service Blood and Transplant, Cambridge, UK.
Nature cancer
|August 7, 2023
概括
明显的骨髓会影响具有突变的造血干细胞 (HSC) 的生长和JAK抑制剂反应. 这些HSC-利基互动调节髓瘤恶性瘤的发展和治疗结果.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 干细胞生物学 干细胞生物学
背景情况:
- 衰老促进了血造干细胞 (HSC) 突变的扩张,导致诸如骨髓增殖性瘤 (MPNs) 等髓状瘤.
- 不同骨髓 (BM) 利基对具有相同致癌驱动因子的HSCs行为的影响尚不清楚.
- 了解利基特定效应对于开发向疗法至关重要.
研究的目的:
- 为了研究不同的BM基区如何影响MPN亚型中携带相同癌原驱动物的HSC.
- 探索JAK-STAT信号和HSC极性在利基相互作用和突变细胞扩张中的作用.
- 为了确定利基互动是否影响对JAK抑制剂的临床反应.
主要方法:
- 在不同MPN亚型中对BM的比较分析.
- 研究JAK-STAT信号通路和CDC42依赖的HSC极性.
- 评估HSC分布和BM小区重塑 (阴影扩张,内骨小区扩张).
- 在老年BM微环境中评估MPN的发展,以及对JAK抑制剂的反应.
主要成果:
- 在不同的MPN亚型中,针对HSC确定了不同的BM.
- JAK-STAT信号差异调节高细胞极性,利基相互作用和突变细胞扩张.
- 不对称的HSC分布导致了特定的利基重塑:在真多细胞血症中发生鼻状扩张,在精髓血小板血小板血小板血小板血小板血小板血小板血小板血小板血小板血小板的扩张.
- 在老年BM微环境中,MPN的发展加速,这表明突变细胞扩张的利基调节.
- 对JAK抑制剂的可变临床反应与不相似的HSC-niche相互作用相关.
结论:
- HSC-niche相互作用显著影响具有克隆性血液形成驱动器的细胞扩张率.
- 专门的BM可以调节突变细胞扩张和MPN的疾病进展.
- 了解这些相互作用是预测和改善患者对JAK抑制剂等向疗法的反应的关键.
更多相关视频
11:06Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
8.0K
08:34Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells
Published on: September 28, 2022
4.3K
相关概念视频
Stem Cell Niche
5.2K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.2K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
